The Oxford-AstraZeneca vaccine
Jewel in the crown of the UK jab campaign has faced harsh scrutiny in Europe

1. European scepticism
Blame game?
Even the most ardent supporter of the government would struggle to deny that the UK’s pandemic response has had its fair share of low points. But in one regard the country has streaked ahead of its neighbours: vaccinations.
The Oxford-AstraZeneca vaccine is the jewel in the crown of the jab rollout that has so far seen more than 30 million people receive at least one dose.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But despite the positive data emerging from the UK, the Oxford University-developed jab has repeatedly faced criticism and suspicion from European nations.
Why has the Oxford-AstraZeneca vaccine faced so much scrutiny?
2. Fresh concerns raised in US
US VS AZ
As scrutiny of the Oxford-AstraZeneca vaccine continues to dominate headlines in Europe, US health officials have waded into the row to raise fresh doubts about the jab.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
In what The Wall Street Journal describes as the “latest misstep by the British drug giant”, AstraZeneca has been left scrambling to update its efficacy data after the US National Institute of Allergy and Infectious Diseases (NIAID) “took the rare move of publicly questioning” the accuracy of the company’s human trials.
The US government health agency issued a statement saying that the independent Data and Safety Monitoring Board (DSMB) had found that AstraZeneca “may have included outdated information” that “may have provided an incomplete view of the efficacy data”.
US health officials question AstraZeneca vaccine trial data
3. Trust in vaccine falls in Europe
Fear factor
Confidence in the Oxford-AstraZeneca Covid vaccine has plummeted across Europe after a host of European governments suspended its use, a survey has found.
Polling by YouGov found that more than half of respondents in France, Germany and Spain now believe the vaccine to be unsafe – even after all three nations later reversed their decision to stop using the UK-developed vaccine.
In France, 61% of respondents said the vaccine was unsafe, an increase of 18 percentage points from February, while 55% of Germans and 52% of Spanish people felt the same way. Figures collected elsewhere are no more promising, with 43% of Italians saying that they also feel the vaccine is not safe for use.
Trust in Oxford-AstraZeneca vaccine collapsing across Europe, poll reveals
4. UK cases in decline
glimmer of hope
A single dose of the Oxford-AstraZeneca vaccine may have a “substantial effect” on curbing the spread of Covid-19 and provide sustained protection against the virus for at least three months, a new study has found.
Test results from the University of Oxford published in a pre-print report in The Lancet show that the first shot may reduce transmission among people who have had the jab by 67% while providing an average of 76% protection against symptomatic infections from three weeks until 90 days.
In a finding that appears to support the UK’s decision to delay second doses, the research also indicates “that spacing out the second dose by a longer period in fact further increases its efficacy”, reports Politico’s London Playbook.
What does Oxford vaccine efficacy mean for getting back to normal life?
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
Southern barbecue: This year’s top three
Feature A weekend-only restaurant, a 90-year-old pitmaster, and more
-
Film reviews: Anemone and The Smashing Machine
Feature A recluse receives an unwelcome guest and a pioneering UFC fighter battles addiction
-
Music reviews: Geese, Jeff Tweedy, and Mariah Carey
Feature “Getting Killed,” “Twilight Override,” and “Here for It All”
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Why are autism rates increasing?
The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Unraveling autism: RFK Jr.'s vow to find a root cause
Feature RFK Jr. has vowed to find the root cause of the 'autism epidemic' in months. Scientists have doubts.